渗透
发表于 2025-3-25 05:34:00
IgG4-Related Disease,oid responsiveness. IgG4-RD responds well to steroids, but it sometimes relapses. Rituximab has recently been reported to be useful for its treatment. Although the short-term outcome is usually good, the long-term prognosis is unknown.
A精确的
发表于 2025-3-25 07:31:18
http://reply.papertrans.cn/83/8213/821271/821271_22.png
FRAX-tool
发表于 2025-3-25 14:52:04
Remitting Seronegative Symmetrical Synovitis and Pitting Edema,racteristics of RS3PE, associated conditions including malignancy, diagnosis and management, as well as current data on mechanism of disease pathogenesis including areas of ongoing research and future directions.
评论性
发表于 2025-3-25 15:59:17
2524-7794 umatic Diseases of Immunologic Dysregulation. is an invaluable resource for rheumatologists, rheumatology fellows, and clinical immunologists to better diagnose and treat patients with rare rheumatic diseases..978-3-319-99138-2978-3-319-99139-9Series ISSN 2524-7794 Series E-ISSN 2524-7808
工作
发表于 2025-3-25 23:51:53
978-3-319-99138-2Springer Nature Switzerland AG 2019
ODIUM
发表于 2025-3-26 00:57:05
Rare Rheumatic Diseases of Immunologic Dysregulation978-3-319-99139-9Series ISSN 2524-7794 Series E-ISSN 2524-7808
Medicaid
发表于 2025-3-26 07:32:41
http://reply.papertrans.cn/83/8213/821271/821271_27.png
maladorit
发表于 2025-3-26 11:45:44
http://reply.papertrans.cn/83/8213/821271/821271_28.png
ear-canal
发表于 2025-3-26 14:48:36
https://doi.org/10.1007/978-3-319-99139-9Rheumatology; Immunologic Dysregulation; Rare Diseases; Diagnosis; Treatment; Immunology
BORE
发表于 2025-3-26 17:43:31
http://reply.papertrans.cn/83/8213/821271/821271_30.png